Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Mol Cancer Res. 2019 Jan 16;17(5):1075–1086. doi: 10.1158/1541-7786.MCR-18-0996

Table 2.

Description of the prognostic germline variants identified in this study.

(A) A description of the two prognostic germline variants (FDR<0.10) in the TCGA dataset identified when testing all 196,022 germline variants.

(B) A description of the prognostic germline variant (FDR<0.10) rs34988193 in ANKDD1a identified when the analysis was restricted to only germline variants with a combined annotation dependent depletion (CADD) score greater than 30 in the TCGA and CGGA datasets.

Table 2A
Variant Chrom Pos Ref Alt Population
Frequency
Sample
Size
Number of
Heterozygotes
Number of
Homozygotes
Gene
Name
Median
Expression
(FPKM)
p-value Hazard Ratio
rs61757955 17 75318086 A G 5.01% 291 21 0 GRB2 42.2 7.08E-10 20.4
rs28672782 11 1446622 C T 16.27% 50 15 5 BRSK2 7.29 <1E-16 1.15E-10
Table 2B
Variant Chrom Pos Ref Alt Population
Frequency
CADD
Score
PhyloP Score Gene Name Dataset Sample
Size
Number of
Heterozygotes
Number of
Homozygotes
p-value Hazard
Ratio
rs34988193 15 64943580 A G 30.90% 32 8.42 ANKDD1a TCGA 450 199 52 0.00113 1.73
CGGA 76 18 2 0.0743 1.79